相关实验视频
Updated: Jul 13, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
在小细胞肺癌中Tarlatamab后的早期伪进展:一个病例报告
Yoshio Nakano1, Hiroka Serizawa1, Yuri Enomoto1
1Department of Respiratory Medicine Sakai City Medical Center Sakai Osaka Japan.
Respirology case reports
|August 19, 2025
概括
一名患有小细胞肺癌的患者在治疗tarlatamab后经历了早期伪进展. 这种短暂的瘤爆发,标志着放射性变化,先于显著的病变回归和生物标志物改善,表明潜在的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伪进展是癌症免疫治疗中已知的现象.
- 塔拉塔马布是小细胞肺癌 (SCLC) 的双特异性T细胞参与者.
- 之前没有报告过tarlatamab的伪进展情况.
研究的目的:
- 在SCLC中报告tarlatamab治疗后潜在的伪进展病例.
- 调查与早期Tarlatamab管理相关的临床过程和成像发现.
- 探索放射变化,生物标志物和治疗反应之间的关系.
主要方法:
- 一个57岁的妇女的病例报告,患有广泛的SCLC和SIADH.
- 使用tarlatamab作为第三线治疗.
- 连续成像 (第7天和第13天) 和亲胃释放 (pro-GRP) 监测.
主要成果:
- 最初的成像显示瘤胀和胸腔溢液,模仿进展.
- 细胞学仍然为阴性,血清水平上升.
- 随后的成像显示胸部和肝脏病变的回归.
- 前胃腺释放 (前胃腺释放) (前胃腺释放) 的水平下降.
结论:
- 这种情况表明,在SCLC中,tarlatamab可能会出现早期的伪进展.
- 随着瘤回归的过渡性放射性变化可能表明治疗的有效性.
- 监测像pro-GRP这样的生物标志物以及成像对于解释治疗反应至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11:17Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...